Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model
about
In vitro optimization of EtNBS-PDT against hypoxic tumor environments with a tiered, high-content, 3D model optical screening platform.Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugatesMinimally-invasive debulking of ovarian cancer in the rat pelvis by means of photodynamic therapy using the pegylated photosensitizer PEG-m-THPC.Photosensitizer and peptide-conjugated PAMAM dendrimer for targeted in vivo photodynamic therapy.Effects of combination of melatonin and laser irradiation on ovarian cancer cells and endothelial lineage viability.BPD-MA-mediated photosensitization in vitro and in vivo: cellular adhesion and beta1 integrin expression in ovarian cancer cellsBiodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancerSynthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapyImpact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer.Immunotherapy: a way to improve the therapeutic outcome of photodynamic therapy?Photosensitiser-antibody conjugates for photodynamic therapy.Enhancing photodynamyc therapy efficacy by combination therapy: dated, current and oncoming strategiesAntibodies armed with photosensitizers: from chemical synthesis to photobiological applications.Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate.Nuclear estrogen receptor targeted photodynamic therapy: selective uptake and killing of MCF-7 breast cancer cells by a C17alpha-alkynylestradiol-porphyrin conjugate.A light-reflecting balloon catheter for atraumatic tissue defect repair.Highly fluorescent protein labeling using dendritic peptide derivatives.Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates.Polymeric nanocarrier systems for photodynamic therapy.Improved targeting of photosensitizers by intratumoral administration of immunoconjugates.Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.Core-Shell-structured Dendritic Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Antibody Delivery.
P2860
Q30531713-299898FB-55B2-4102-860B-04BB6987F61EQ30574141-5B385E80-5B7C-48D6-8248-668262E70A9DQ30818425-B93E5729-300E-4520-93C3-9F932F0102F1Q35851983-9B731081-D443-44D0-99F0-31A19DA23E45Q36065479-5848F692-3880-468E-9AFF-D575AACD850BQ36620229-5213E491-7D00-4EB5-82DA-309810AFD855Q36621534-8F314408-05A0-4FB5-8C5A-5AEED37178D5Q36982369-E643587A-9990-41B8-8B7B-52A0A63D7CF8Q37197458-407F2EFF-8AA5-416F-A0C2-3C8A522B8FC7Q37255029-C7E053D2-B53F-4274-B4D4-8861A8C6E8C7Q37853421-D9FE6FC6-DD8A-4A9B-A9B8-2DE358F753F8Q38161363-418277FB-6C33-40AC-A426-F1D937CB21D8Q38328583-4EFCB194-9854-431B-B360-7B159E7C502FQ40263426-B141E001-C022-40E1-BBBB-BF733783BFFCQ40272207-E707927F-8A82-411D-8366-9417C695C5C2Q40508162-FE4C4613-6185-491C-90D1-9844E2490D28Q40772838-D9D6BF1B-D9BC-4627-AC71-58D12C142246Q41850842-789DD815-1A1B-49EB-BDA4-310B10AA7A91Q42176559-8B8788DA-19F3-48F9-8E48-808EA125BCC2Q47434627-2F3C99FA-F9BF-4D85-A777-8DD7B1C4A1B3Q47599219-C0427C6A-4D90-445A-A2A1-9F880D9DDC41Q51015445-04E7F233-AEBB-4468-9B63-AA97253A8074
P2860
Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Treatment of ovarian cancer wi ...... a murine ovarian cancer model
@ast
Treatment of ovarian cancer wi ...... a murine ovarian cancer model
@en
type
label
Treatment of ovarian cancer wi ...... a murine ovarian cancer model
@ast
Treatment of ovarian cancer wi ...... a murine ovarian cancer model
@en
prefLabel
Treatment of ovarian cancer wi ...... a murine ovarian cancer model
@ast
Treatment of ovarian cancer wi ...... a murine ovarian cancer model
@en
P2093
P2860
P356
P1476
Treatment of ovarian cancer wi ...... a murine ovarian cancer model
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.516
P407
P577
1996-10-01T00:00:00Z
P5875
P6179
1024516437